No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy
<p>Background: The majority of anal cancers (84-95%) are driven by infection with human papillomavirus (HPV). HPV-positive tumours show significantly better responses to chemoradiotherapy when compared to HPV-negative tumours. HPV infection is linked to alterations in DNA damage response prote...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Cancer Research UK
2017
|
| _version_ | 1797071010886844416 |
|---|---|
| author | Walker, A Kartsonaki, C Collantes, E Nicholson, J Gilbert, D Kiltie, A |
| author_facet | Walker, A Kartsonaki, C Collantes, E Nicholson, J Gilbert, D Kiltie, A |
| author_sort | Walker, A |
| collection | OXFORD |
| description | <p>Background: The majority of anal cancers (84-95%) are driven by infection with human papillomavirus (HPV). HPV-positive tumours show significantly better responses to chemoradiotherapy when compared to HPV-negative tumours. HPV infection is linked to alterations in DNA damage response proteins, including MRE11. MRE11 is a potential predictive biomarker for response to radiotherapy in muscle-invasive bladder cancer and may hold predictive power in other cancers.</p><p> Methods: Using a previously reported cohort we evaluated the levels of MRE11 in anal cancer and assessed its predictive value in this disease.</p><p> Results: We found no association between the level of MRE11 and relapse-free survival following chemo-radiotherapy.</p><p> Conclusion: MRE11 has no predictive value in the analysis of relapse-free survival after chemoradiotherapy in anal cancer and does not add to the prognostic value of p16 and tumour infiltrating lymphocyte (TIL) scores. Further investigation into the role of DNA repair proteins in anal cancer is required.</p> |
| first_indexed | 2024-03-06T22:47:07Z |
| format | Journal article |
| id | oxford-uuid:5d8ba69d-5a26-40a1-8f8a-774184e1e44b |
| institution | University of Oxford |
| last_indexed | 2024-03-06T22:47:07Z |
| publishDate | 2017 |
| publisher | Cancer Research UK |
| record_format | dspace |
| spelling | oxford-uuid:5d8ba69d-5a26-40a1-8f8a-774184e1e44b2022-03-26T17:35:11ZNo additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5d8ba69d-5a26-40a1-8f8a-774184e1e44bSymplectic Elements at OxfordCancer Research UK2017Walker, AKartsonaki, CCollantes, ENicholson, JGilbert, DKiltie, A<p>Background: The majority of anal cancers (84-95%) are driven by infection with human papillomavirus (HPV). HPV-positive tumours show significantly better responses to chemoradiotherapy when compared to HPV-negative tumours. HPV infection is linked to alterations in DNA damage response proteins, including MRE11. MRE11 is a potential predictive biomarker for response to radiotherapy in muscle-invasive bladder cancer and may hold predictive power in other cancers.</p><p> Methods: Using a previously reported cohort we evaluated the levels of MRE11 in anal cancer and assessed its predictive value in this disease.</p><p> Results: We found no association between the level of MRE11 and relapse-free survival following chemo-radiotherapy.</p><p> Conclusion: MRE11 has no predictive value in the analysis of relapse-free survival after chemoradiotherapy in anal cancer and does not add to the prognostic value of p16 and tumour infiltrating lymphocyte (TIL) scores. Further investigation into the role of DNA repair proteins in anal cancer is required.</p> |
| spellingShingle | Walker, A Kartsonaki, C Collantes, E Nicholson, J Gilbert, D Kiltie, A No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy |
| title | No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy |
| title_full | No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy |
| title_fullStr | No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy |
| title_full_unstemmed | No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy |
| title_short | No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy |
| title_sort | no additional prognostic value for mre11 in squamous cell carcinomas of the anus treated with chemo radiotherapy |
| work_keys_str_mv | AT walkera noadditionalprognosticvalueformre11insquamouscellcarcinomasoftheanustreatedwithchemoradiotherapy AT kartsonakic noadditionalprognosticvalueformre11insquamouscellcarcinomasoftheanustreatedwithchemoradiotherapy AT collantese noadditionalprognosticvalueformre11insquamouscellcarcinomasoftheanustreatedwithchemoradiotherapy AT nicholsonj noadditionalprognosticvalueformre11insquamouscellcarcinomasoftheanustreatedwithchemoradiotherapy AT gilbertd noadditionalprognosticvalueformre11insquamouscellcarcinomasoftheanustreatedwithchemoradiotherapy AT kiltiea noadditionalprognosticvalueformre11insquamouscellcarcinomasoftheanustreatedwithchemoradiotherapy |